HERG Screening Market: Information By Type (Gene KCNH2, Mutant KCNH2), Ion Channel (Voltage-gated ion channel, Ligand-gated ion channel), Application (Antiarrhythmic, Antipsychotic, Antibiotics) and Region (Americas, Europe, Asia-Pacific and the Middle East and Africa) - Forecast till 2027
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/10386
HERG Screening Market is expected to register a CAGR of 13.85% during the assessment period of 2020 to 2027, to reach USD 3,304.58 Million by 2027. HERG screening has been an important component of cardiac safety-pharmacology from the past many years. hERG was identified as a potassium-selective cardiac ion channel, Kv11.1, which plays an important role during cardiac repolarization.
Segment Analysis
Global hERG Screening Market is segmented into Type, i.e., gene KCNH2 and mutant KCNH2. KCNH2 gene that provides guidelines for producing potassium channels and held the largest market share in the hERG screening market. The global hERG screening market is segmented based on ion channel, further bifurcated into voltage-gated ion channel, ligand-gated ion channel, and others. Voltage-gated ion channel held the largest share in the hERG screening market, whereas ion-gated channel is the fastest-growing segment. The application segment is divided into antiarrhythmic drugs, antipsychotics, antibiotics, and others. The antiarrhythmic drug application segment is projected to account for a considerable market share.
Regional Analysis
The global hERG screening market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas held the largest share of 37.3% of the hERG screening market in 2019. This share can be attributed to technological development and the high prevalence of cardiac disease in the region.
The Europe hERG screening market has been segmented into Western Europe and Eastern Europe. The Western Europe hERG screening market has further been classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The major players of these countries are involved in new launches and acquisitions in the hERG screening market. The hERG screening market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The market growth in these countries is attributed to the large pool of patients suffering from cardiac disorders and the need for drug formulation and development to cure these disorders. The Middle East & Africa hERG screening market has been divided into the Middle East and Africa.
Key Players
MRFR recognizes the following companies as the Key Players in the Global hERG Screening Market—Thermo Fisher Scientific, Eurofins Discover X Corporation, Charles River Laboratories, Merck KGaA, Metrion Biosciences Ltd, and Aurora Biomed, Inc.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/herg-screening-market-10386
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
